Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
NCT00900406 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 190
Last updated 2012-11-06
Summary
RATIONALE: Collecting and storing samples of blood, urine, and tissue from patients undergoing a donor stem cell transplant to test in the laboratory may help the study of graft-versus-host disease in the future.
PURPOSE: This research study is collecting and storing tissue and DNA samples from patients undergoing a donor stem cell transplant.
Conditions
- Breast Cancer
- Chronic Myeloproliferative Disorders
- Gestational Trophoblastic Tumor
- Graft Versus Host Disease
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms
- Neuroblastoma
- Ovarian Cancer
- Testicular Germ Cell Tumor
Interventions
- GENETIC
-
gene expression analysis
blood collection
- GENETIC
-
microarray analysis
Blood collection
- GENETIC
-
polymorphism analysis
Blood collection
- GENETIC
-
proteomic profiling
Blood collection
- OTHER
-
flow cytometry
Blood collection
- OTHER
-
immunologic technique
Blood collection
- OTHER
-
laboratory biomarker analysis
Blood collection
- PROCEDURE
-
biopsy
Blood collection
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Vanderbilt-Ingram Cancer Center
lead OTHER
Principal Investigators
-
Madan Jagasia, MD · Vanderbilt-Ingram Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- United States
Study Locations
More Related Trials
-
Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant
NCT00361049 ·Status: COMPLETED ·Phase: PHASE1
-
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
NCT00001623 ·Status: COMPLETED ·Phase: NA
-
Graft-versus-host Disease Associated Myelosuppression
NCT02829216 ·Status: UNKNOWN
-
Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
NCT00725062 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
NCT00179049 ·Status: COMPLETED
-
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
NCT01890486 ·Status: RECRUITING
-
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
NCT06856226 ·Status: RECRUITING
-
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT00003538 ·Status: COMPLETED ·Phase: NA
-
Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant
NCT02240381 ·Status: TERMINATED ·Phase: NA
-
Unrelated Donor Stem Cell Transplantation
NCT01364363 ·Status: COMPLETED ·Phase: NA
-
In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells
NCT00731705 ·Status: WITHDRAWN
-
Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
NCT00179075 ·Status: COMPLETED
-
Feasibility Study of Collecting Multicenter Chronic GVHD Data
NCT00506233 ·Status: COMPLETED
-
Stem Cell Transplantation for Patients With Cancers of the Blood
NCT00467961 ·Status: COMPLETED ·Phase: PHASE2
-
Precision Medicine for Stem Cell Transplantation
NCT05567289 ·Status: RECRUITING
-
Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation
NCT06715046 ·Status: RECRUITING
-
Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.
NCT01174277 ·Status: COMPLETED
-
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
NCT03000244 ·Status: RECRUITING
-
Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients
NCT00578630 ·Status: COMPLETED
-
High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant
NCT03719092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
NCT06649201 ·Status: RECRUITING
-
Efficacy and Safety of High Dose Vitamin D Supplementation in Patients Undergoing HSCT
NCT03320915 ·Status: UNKNOWN ·Phase: PHASE2
-
Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant
NCT02526329 ·Status: WITHDRAWN ·Phase: PHASE1
-
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
NCT02579967 ·Status: RECRUITING ·Phase: PHASE2
-
Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
NCT00295880 ·Status: TERMINATED ·Phase: PHASE1/PHASE2